메뉴 건너뛰기




Volumn 167, Issue 2, 2014, Pages 162-176

Erratum to Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age" [Journal of Haematology, 167, 2, October (2014), 162-167] doi 10.1111/bjh.13048;Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age

Author keywords

Acute myeloid leukaemia; Diagnostic haematology; Leukaemia markers; Minimal residual disease; Prognostic factors

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; BONE MARROW BIOPSY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CRYOPRESERVATION; CYTOGENETICS; FLOW CYTOMETRY; FOLLOW UP; GENOMICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MINIMAL RESIDUAL DISEASE; MOLECULAR EVOLUTION; MOLECULAR GENETICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; BONE MARROW; CHROMOSOME ANALYSIS; GENETICS; LEUKEMIA, MYELOID, ACUTE; LONG TERM CARE; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PROCEDURES; PROGNOSIS; REMISSION;

EID: 84908510277     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13311     Document Type: Erratum
Times cited : (9)

References (112)
  • 2
    • 0033556427 scopus 로고    scopus 로고
    • Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia
    • Aggerholm, A., Guldberg, P., Hokland, M. & Hokland, P. (1999) Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Research, 59, 436-441.
    • (1999) Cancer Research , vol.59 , pp. 436-441
    • Aggerholm, A.1    Guldberg, P.2    Hokland, M.3    Hokland, P.4
  • 3
    • 58549114892 scopus 로고    scopus 로고
    • The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia
    • Al-Mawali, A., Gillis, D. & Lewis, I. (2009) The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia. American Journal of Clinical Pathology, 131, 16-26.
    • (2009) American Journal of Clinical Pathology , vol.131 , pp. 16-26
    • Al-Mawali, A.1    Gillis, D.2    Lewis, I.3
  • 12
    • 84879841453 scopus 로고    scopus 로고
    • Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation
    • Campana, D. & Leung, W. (2013) Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation. British Journal of Haematology, 162, 147-161.
    • (2013) British Journal of Haematology , vol.162 , pp. 147-161
    • Campana, D.1    Leung, W.2
  • 13
    • 84878372012 scopus 로고    scopus 로고
    • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
    • Cancer Genome Atlas Research Network (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. The New England Journal of Medicine, 368, 2059-2074.
    • (2013) The New England Journal of Medicine , vol.368 , pp. 2059-2074
  • 14
    • 77949453508 scopus 로고    scopus 로고
    • Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology
    • ten Cate, B., de Bruyn, M., Wei, Y., Bremer, E. & Helfrich, W. (2010) Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology. Current Drug Targets, 11, 95-110.
    • (2010) Current Drug Targets , vol.11 , pp. 95-110
    • ten Cate, B.1    de Bruyn, M.2    Wei, Y.3    Bremer, E.4    Helfrich, W.5
  • 16
    • 1542753559 scopus 로고    scopus 로고
    • Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
    • Cheson, B.D. (2003) Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. Journal of Clinical Oncology, 21, 4642-4649.
    • (2003) Journal of Clinical Oncology , vol.21 , pp. 4642-4649
    • Cheson, B.D.1
  • 18
    • 84873341730 scopus 로고    scopus 로고
    • Should evaluation for minimal residual disease be routine in acute myeloid leukemia?
    • Coustan-Smith, E. & Campana, D. (2013) Should evaluation for minimal residual disease be routine in acute myeloid leukemia? Current Opinion in Hematology, 20, 86-92.
    • (2013) Current Opinion in Hematology , vol.20 , pp. 86-92
    • Coustan-Smith, E.1    Campana, D.2
  • 19
    • 43249130717 scopus 로고    scopus 로고
    • Flow cytometric immunophenotyping for hematologic neoplasms
    • Craig, F. & Foon, K. (2008) Flow cytometric immunophenotyping for hematologic neoplasms. Blood, 111, 3941-3967.
    • (2008) Blood , vol.111 , pp. 3941-3967
    • Craig, F.1    Foon, K.2
  • 21
    • 84856889380 scopus 로고    scopus 로고
    • Beyond morphology: minimal residual disease detection in acute myeloid leukemia
    • Dinardo, C.D. & Luger, S.M. (2012) Beyond morphology: minimal residual disease detection in acute myeloid leukemia. Current Opinion in Hematology, 19, 82-88.
    • (2012) Current Opinion in Hematology , vol.19 , pp. 82-88
    • Dinardo, C.D.1    Luger, S.M.2
  • 24
    • 0036682174 scopus 로고    scopus 로고
    • Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm
    • Döhner, K., Tobis, K., Ulrich, R., Fröhling, S., Benner, A., Schlenk, R.F. & Döhner, H. (2002) Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. Journal of Clinical Oncology, 20, 3254-3261.
    • (2002) Journal of Clinical Oncology , vol.20 , pp. 3254-3261
    • Döhner, K.1    Tobis, K.2    Ulrich, R.3    Fröhling, S.4    Benner, A.5    Schlenk, R.F.6    Döhner, H.7
  • 26
    • 79955952683 scopus 로고    scopus 로고
    • Overexpression of IL-3Rα on CD34+CD38- stem cells defines leukemia-initiating cells in FA AML
    • Du, W., Li, X., Sipple, J. & Pang, Q. (2011) Overexpression of IL-3Rα on CD34+CD38- stem cells defines leukemia-initiating cells in FA AML. Blood, 117, 4243-4252.
    • (2011) Blood , vol.117 , pp. 4243-4252
    • Du, W.1    Li, X.2    Sipple, J.3    Pang, Q.4
  • 28
    • 84055218304 scopus 로고    scopus 로고
    • Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management
    • Estey, E.H. (2012) Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management. American Journal of Hematology, 87, 89-99.
    • (2012) American Journal of Hematology , vol.87 , pp. 89-99
    • Estey, E.H.1
  • 29
    • 84875632298 scopus 로고    scopus 로고
    • Acute myeloid leukemia: 2013 update on risk-stratification and management
    • Estey, E.H. (2013) Acute myeloid leukemia: 2013 update on risk-stratification and management. American Journal of Hematology, 88, 318-327.
    • (2013) American Journal of Hematology , vol.88 , pp. 318-327
    • Estey, E.H.1
  • 30
    • 74049158596 scopus 로고    scopus 로고
    • Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
    • Falini, B., Sportoletti, P. & Martelli, M.P. (2009) Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. Current Opinion in Oncology, 21, 573-581.
    • (2009) Current Opinion in Oncology , vol.21 , pp. 573-581
    • Falini, B.1    Sportoletti, P.2    Martelli, M.P.3
  • 38
    • 77954921625 scopus 로고    scopus 로고
    • Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations
    • Green, C.L., Koo, K.K., Hills, R.K., Burnett, A.K., Linch, D.C. & Gale, R.E. (2010) Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. Journal of Clinical Oncology, 28, 2739-2747.
    • (2010) Journal of Clinical Oncology , vol.28 , pp. 2739-2747
    • Green, C.L.1    Koo, K.K.2    Hills, R.K.3    Burnett, A.K.4    Linch, D.C.5    Gale, R.E.6
  • 39
    • 0034758836 scopus 로고    scopus 로고
    • The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
    • Grimwade, D. (2001) The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Practice & Research Clinical Haematology, 14, 497-529.
    • (2001) Best Practice & Research Clinical Haematology , vol.14 , pp. 497-529
    • Grimwade, D.1
  • 41
    • 77955914238 scopus 로고    scopus 로고
    • Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
    • Grimwade, D., Hills, R.K., Moorman, A.V., Walker, H., Chatters, S., Goldstone, A.H., Wheatley, K., Harrison, C.J. & Burnett, A.K.; National Cancer Research Institute Adult Leukaemia Working Group (2010a) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood, 116, 354-365.
    • (2010) Blood , vol.116 , pp. 354-365
    • Grimwade, D.1    Hills, R.K.2    Moorman, A.V.3    Walker, H.4    Chatters, S.5    Goldstone, A.H.6    Wheatley, K.7    Harrison, C.J.8    Burnett, A.K.9
  • 42
    • 77958468721 scopus 로고    scopus 로고
    • Assessment of minimal residual disease in acute myeloid leukemia
    • Grimwade, D., Vyas, P. & Freeman, S. (2010b) Assessment of minimal residual disease in acute myeloid leukemia. Current Opinion in Oncology, 22, 656-663.
    • (2010) Current Opinion in Oncology , vol.22 , pp. 656-663
    • Grimwade, D.1    Vyas, P.2    Freeman, S.3
  • 44
    • 84881663530 scopus 로고    scopus 로고
    • High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group
    • Ho, P.A., Alonzo, T.A., Gerbing, R.B., Pollard, J.A., Hirsch, B., Raimondi, S.C., Cooper, T., Gamis, A.S. & Meshinchi, S. (2013) High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group. British Journal of Haematology, 162, 670-677.
    • (2013) British Journal of Haematology , vol.162 , pp. 670-677
    • Ho, P.A.1    Alonzo, T.A.2    Gerbing, R.B.3    Pollard, J.A.4    Hirsch, B.5    Raimondi, S.C.6    Cooper, T.7    Gamis, A.S.8    Meshinchi, S.9
  • 45
    • 84865128557 scopus 로고    scopus 로고
    • Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission-methodologies in relation to their clinical situation
    • Hokland, P., Ommen, H.B., Nyvold, C.G. & Roug, A.S. (2012) Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission-methodologies in relation to their clinical situation. British Journal of Haematology, 158, 569-580.
    • (2012) British Journal of Haematology , vol.158 , pp. 569-580
    • Hokland, P.1    Ommen, H.B.2    Nyvold, C.G.3    Roug, A.S.4
  • 48
  • 49
    • 84870720777 scopus 로고    scopus 로고
    • Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia
    • How, J., Sykes, J., Gupta, V., Yee, K.W.L., Schimmer, A.D., Schuh, A.C., Minden, M.D., Kamel-Reid, S. & Brandwein, J.M. (2012) Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia. Cancer, 118, 6110-6117.
    • (2012) Cancer , vol.118 , pp. 6110-6117
    • How, J.1    Sykes, J.2    Gupta, V.3    Yee, K.W.L.4    Schimmer, A.D.5    Schuh, A.C.6    Minden, M.D.7    Kamel-Reid, S.8    Brandwein, J.M.9
  • 52
    • 33749515476 scopus 로고    scopus 로고
    • Targeting of CD44 eradicates human acute myeloid leukemic stem cells
    • Jin, L., Hope, K.J., Zhai, Q., Smadja-Joffe, F. & Dick, J.E. (2006) Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nature Medicine, 12, 1167-1174.
    • (2006) Nature Medicine , vol.12 , pp. 1167-1174
    • Jin, L.1    Hope, K.J.2    Zhai, Q.3    Smadja-Joffe, F.4    Dick, J.E.5
  • 55
    • 66149148673 scopus 로고    scopus 로고
    • Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
    • Juliusson, G., Antunovic, P., Derolf, A., Lehmann, S., Möllgård, L., Stockelberg, D., Tidefelt, U., Wahlin, A. & Höglund, M. (2009) Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood, 113, 4179-4187.
    • (2009) Blood , vol.113 , pp. 4179-4187
    • Juliusson, G.1    Antunovic, P.2    Derolf, A.3    Lehmann, S.4    Möllgård, L.5    Stockelberg, D.6    Tidefelt, U.7    Wahlin, A.8    Höglund, M.9
  • 59
    • 84904871973 scopus 로고    scopus 로고
    • Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing
    • Kohlmann, A., Bacher, U., Schnittger, S. & Haferlach, T. (2014) Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing. Leukemia & Lymphoma, 55, 1725-1734.
    • (2014) Leukemia & Lymphoma , vol.55 , pp. 1725-1734
    • Kohlmann, A.1    Bacher, U.2    Schnittger, S.3    Haferlach, T.4
  • 63
    • 84155172363 scopus 로고    scopus 로고
    • Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up
    • Larsen, H.Ø., Roug, A.S., Just, T., Brown, G.D. & Hokland, P. (2012) Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up. Cytometry Part B, Clinical Cytometry, 82, 3-8.
    • (2012) Cytometry Part B, Clinical Cytometry , vol.82 , pp. 3-8
    • Larsen, H.1    Roug, A.S.2    Just, T.3    Brown, G.D.4    Hokland, P.5
  • 66
    • 84896028589 scopus 로고    scopus 로고
    • Prognostic factors for acute myeloid leukaemia in adults - biological significance and clinical use
    • Liersch, R., Müller-Tidow, C., Berdel, W.E. & Krug, U. (2014) Prognostic factors for acute myeloid leukaemia in adults - biological significance and clinical use. British Journal of Haematology, 165, 17-38.
    • (2014) British Journal of Haematology , vol.165 , pp. 17-38
    • Liersch, R.1    Müller-Tidow, C.2    Berdel, W.E.3    Krug, U.4
  • 67
    • 1942442136 scopus 로고    scopus 로고
    • Rapid diagnosis and characterization of acute promyelocytic leukaemia in routine laboratory practice
    • Lock, R.J., Virgo, P.F., Kitchen, C. & Evely, R.S. (2004) Rapid diagnosis and characterization of acute promyelocytic leukaemia in routine laboratory practice. Clinical and Laboratory Haematology, 26, 101-106.
    • (2004) Clinical and Laboratory Haematology , vol.26 , pp. 101-106
    • Lock, R.J.1    Virgo, P.F.2    Kitchen, C.3    Evely, R.S.4
  • 69
    • 67650632683 scopus 로고    scopus 로고
    • CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells
    • Majeti, R., Chao, M.P., Alizadeh, A.A., Pang, W.W., Jaiswal, S., Gibbs, K.D., van Rooijen, N. & Weissman, I.L. (2009) CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell, 138, 286-299.
    • (2009) Cell , vol.138 , pp. 286-299
    • Majeti, R.1    Chao, M.P.2    Alizadeh, A.A.3    Pang, W.W.4    Jaiswal, S.5    Gibbs, K.D.6    van Rooijen, N.7    Weissman, I.L.8
  • 72
    • 84891625028 scopus 로고    scopus 로고
    • Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia
    • Medeiros, B.C., Othus, M., Estey, E.H., Fang, M. & Appelbaum, F.R. (2014) Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia. British Journal of Haematology, 164, 245-250.
    • (2014) British Journal of Haematology , vol.164 , pp. 245-250
    • Medeiros, B.C.1    Othus, M.2    Estey, E.H.3    Fang, M.4    Appelbaum, F.R.5
  • 74
    • 77955479205 scopus 로고    scopus 로고
    • Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer
    • Mitelman, F., Johansson, B. & Mertens, F. (eds) (2014). Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman
    • (2014)
    • Mitelman, F.1    Johansson, B.2    Mertens, F.3
  • 77
    • 38349053347 scopus 로고    scopus 로고
    • Multiparametric analysis of normal and postchemotherapy bone marrow: implication for the detection of leukemia-associated immunophenotypes
    • Olaru, D., Campos, L., Flandrin, P., Nadal, N., Duval, A., Chautard, S. & Guyotat, D. (2008) Multiparametric analysis of normal and postchemotherapy bone marrow: implication for the detection of leukemia-associated immunophenotypes. Cytometry Part B, Clinical Cytometry, 74, 17-24.
    • (2008) Cytometry Part B, Clinical Cytometry , vol.74 , pp. 17-24
    • Olaru, D.1    Campos, L.2    Flandrin, P.3    Nadal, N.4    Duval, A.5    Chautard, S.6    Guyotat, D.7
  • 78
    • 75649091203 scopus 로고    scopus 로고
    • Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias
    • Ommen, H.B., Schnittger, S., Jovanovic, J.V., Ommen, I.B., Hasle, H., Østergaard, M., Grimwade, D. & Hokland, P. (2010) Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias. Blood, 115, 198-205.
    • (2010) Blood , vol.115 , pp. 198-205
    • Ommen, H.B.1    Schnittger, S.2    Jovanovic, J.V.3    Ommen, I.B.4    Hasle, H.5    Østergaard, M.6    Grimwade, D.7    Hokland, P.8
  • 79
    • 84877930147 scopus 로고    scopus 로고
    • MRD in AML: time for redefinition of CR?
    • Ossenkoppele, G. & Schuurhuis, G.J. (2013) MRD in AML: time for redefinition of CR? Blood, 121, 2166-2168.
    • (2013) Blood , vol.121 , pp. 2166-2168
    • Ossenkoppele, G.1    Schuurhuis, G.J.2
  • 80
  • 82
    • 84879350221 scopus 로고    scopus 로고
    • Minimal residual disease in acute myeloid leukemia: coming of age. Education Program of the American Society of Hematology
    • Paietta, E. (2012) Minimal residual disease in acute myeloid leukemia: coming of age. Education Program of the American Society of Hematology. American Society of Hematology Education Program, 2012, 35-42.
    • (2012) American Society of Hematology Education Program , vol.2012 , pp. 35-42
    • Paietta, E.1
  • 86
    • 34447646569 scopus 로고    scopus 로고
    • Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission
    • van Rhenen, A., Moshaver, B., Kelder, A., Feller, N., Nieuwint, A.W.M., Zweegman, S., Ossenkoppele, G.J. & Schuurhuis, G.J. (2007) Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. Leukemia, 21, 1700-1707.
    • (2007) Leukemia , vol.21 , pp. 1700-1707
    • van Rhenen, A.1    Moshaver, B.2    Kelder, A.3    Feller, N.4    Nieuwint, A.W.M.5    Zweegman, S.6    Ossenkoppele, G.J.7    Schuurhuis, G.J.8
  • 88
    • 84891624172 scopus 로고    scopus 로고
    • hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia
    • Roug, A.S., Larsen, H.Ø., Nederby, L., Just, T., Brown, G., Nyvold, C.G., Ommen, H.B. & Hokland, P. (2013) hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia. British Journal of Haematology, 164, 212-222.
    • (2013) British Journal of Haematology , vol.164 , pp. 212-222
    • Roug, A.S.1    Larsen, H.2    Nederby, L.3    Just, T.4    Brown, G.5    Nyvold, C.G.6    Ommen, H.B.7    Hokland, P.8
  • 92
    • 70349579540 scopus 로고    scopus 로고
    • Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
    • Schnittger, S., Kern, W., Tschulik, C., Weiss, T., Dicker, F., Falini, B., Haferlach, C. & Haferlach, T. (2009) Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML. Blood, 114, 2220-2231.
    • (2009) Blood , vol.114 , pp. 2220-2231
    • Schnittger, S.1    Kern, W.2    Tschulik, C.3    Weiss, T.4    Dicker, F.5    Falini, B.6    Haferlach, C.7    Haferlach, T.8
  • 97
  • 98
    • 33646557337 scopus 로고    scopus 로고
    • Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
    • Thiede, C., Koch, S., Creutzig, E., Steudel, C., Illmer, T., Schaich, M. & Ehninger, G. (2006) Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood, 107, 4011-4020.
    • (2006) Blood , vol.107 , pp. 4011-4020
    • Thiede, C.1    Koch, S.2    Creutzig, E.3    Steudel, C.4    Illmer, T.5    Schaich, M.6    Ehninger, G.7
  • 99
    • 78951476130 scopus 로고    scopus 로고
    • Targeting of leukemia-initiating cells to develop curative drug therapies: straightforward but nontrivial concept
    • Valent, P. (2011) Targeting of leukemia-initiating cells to develop curative drug therapies: straightforward but nontrivial concept. Current Cancer Drug Targets, 11, 56-71.
    • (2011) Current Cancer Drug Targets , vol.11 , pp. 56-71
    • Valent, P.1
  • 101
    • 84856005158 scopus 로고    scopus 로고
    • Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases
    • Veigaard, C., Nørgaard, J.M. & Kjeldsen, E. (2011) Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases. Cancer Genetics, 204, 516-521.
    • (2011) Cancer Genetics , vol.204 , pp. 516-521
    • Veigaard, C.1    Nørgaard, J.M.2    Kjeldsen, E.3
  • 102
    • 7744244145 scopus 로고    scopus 로고
    • Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings
    • Voskova, D., Schoch, C., Schnittger, S., Hiddemann, W., Haferlach, T. & Kern, W. (2004) Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings. Cytometry Part B, Clinical Cytometry, 62, 25-38.
    • (2004) Cytometry Part B, Clinical Cytometry , vol.62 , pp. 25-38
    • Voskova, D.1    Schoch, C.2    Schnittger, S.3    Hiddemann, W.4    Haferlach, T.5    Kern, W.6
  • 103
    • 80052493235 scopus 로고    scopus 로고
    • Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia
    • Wakita, S., Yamaguchi, H., Miyake, K., Mitamura, Y., Kosaka, F., Dan, K. & Inokuchi, K. (2011) Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia. Leukemia, 25, 1423-1432.
    • (2011) Leukemia , vol.25 , pp. 1423-1432
    • Wakita, S.1    Yamaguchi, H.2    Miyake, K.3    Mitamura, Y.4    Kosaka, F.5    Dan, K.6    Inokuchi, K.7
  • 104
    • 81255175041 scopus 로고    scopus 로고
    • Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment
    • Walter, R.B., Othus, M., Borthakur, G., Ravandi, F., Cortes, J.E., Pierce, S.A., Appelbaum, F.R., Kantarjian, H.A. & Estey, E.H. (2011) Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. Journal of Clinical Oncology, 29, 4417-4423.
    • (2011) Journal of Clinical Oncology , vol.29 , pp. 4417-4423
    • Walter, R.B.1    Othus, M.2    Borthakur, G.3    Ravandi, F.4    Cortes, J.E.5    Pierce, S.A.6    Appelbaum, F.R.7    Kantarjian, H.A.8    Estey, E.H.9
  • 105
    • 84876260322 scopus 로고    scopus 로고
    • EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia
    • Wang, X., Dai, H., Wang, Q., Wang, Q., Xu, Y., Wang, Y., Sun, A., Ruan, J., Chen, S. & Wu, D. (2013) EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia. PLoS ONE, 8, e61341.
    • (2013) PLoS ONE , vol.8 , pp. e61341
    • Wang, X.1    Dai, H.2    Wang, Q.3    Wang, Q.4    Xu, Y.5    Wang, Y.6    Sun, A.7    Ruan, J.8    Chen, S.9    Wu, D.10
  • 108
    • 84898045456 scopus 로고    scopus 로고
    • Genomic tools in acute myeloid leukemia: from the bench to the bedside
    • White, B.S. & DiPersio, J.F. (2014) Genomic tools in acute myeloid leukemia: from the bench to the bedside. Cancer, 120, 1134-1144.
    • (2014) Cancer , vol.120 , pp. 1134-1144
    • White, B.S.1    DiPersio, J.F.2
  • 109
    • 84896942225 scopus 로고    scopus 로고
    • Prognostic significance of TP53 mutations and single nucleotide polymorphisms in acute myeloid leukemia: a case series and literature review
    • Zeichner, S.B., Alghamdi, S., Elhammady, G. & Poppiti, R.J. (2014) Prognostic significance of TP53 mutations and single nucleotide polymorphisms in acute myeloid leukemia: a case series and literature review. Asian Pacific Journal of Cancer Prevention, 15, 1603-1609.
    • (2014) Asian Pacific Journal of Cancer Prevention , vol.15 , pp. 1603-1609
    • Zeichner, S.B.1    Alghamdi, S.2    Elhammady, G.3    Poppiti, R.J.4
  • 112
    • 84868342138 scopus 로고    scopus 로고
    • Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis
    • Zhou, K.-G., Jiang, L.-J., Shang, Z., Wang, J., Huang, L. & Zhou, J.-F. (2012) Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis. Leukemia & Lymphoma, 53, 2423-2429.
    • (2012) Leukemia & Lymphoma , vol.53 , pp. 2423-2429
    • Zhou, K.-G.1    Jiang, L.-J.2    Shang, Z.3    Wang, J.4    Huang, L.5    Zhou, J.-F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.